ACTIVE-SEQ Trademark

Trademark Overview


On Tuesday, December 12, 2023, a trademark application was filed for ACTIVE-SEQ with the United States Patent and Trademark Office. The USPTO has given the ACTIVE-SEQ trademark a serial number of 98310054. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 23, 2024. This trademark is owned by Zafrens, Inc.. The ACTIVE-SEQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology and pharmaceutical research services, namely screening and discernment of the reaction of living cells to drug candidates, cellular perturbations, or various other stimuli; discernment and correlation of the functional activity of living cells to the molecular states of the cells; discernment and correlation of the transcriptional and/or translational activity of living cells to the molecular states of the cells; staining or imaging of cells to identify cells' response to stimuli; collection and sequencing or identification of the metabolic products of cells exposed to drug candidates, cellular perturbations, or various other stimuli; screening of living cells to identify cells that react to an antigen or bind to a receptor; T-cell or B-cell discovery and/or screening services; bispecific antibody screening and binding study services; in the area of biotechnology and pharmaceutical research services.
active-seq

General Information


Serial Number98310054
Word MarkACTIVE-SEQ
Filing DateTuesday, December 12, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiotechnology and pharmaceutical research services, namely screening and discernment of the reaction of living cells to drug candidates, cellular perturbations, or various other stimuli; discernment and correlation of the functional activity of living cells to the molecular states of the cells; discernment and correlation of the transcriptional and/or translational activity of living cells to the molecular states of the cells; staining or imaging of cells to identify cells' response to stimuli; collection and sequencing or identification of the metabolic products of cells exposed to drug candidates, cellular perturbations, or various other stimuli; screening of living cells to identify cells that react to an antigen or bind to a receptor; T-cell or B-cell discovery and/or screening services; bispecific antibody screening and binding study services; in the area of biotechnology and pharmaceutical research services.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZafrens, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, December 12, 2023NEW APPLICATION ENTERED
Thursday, March 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 9, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 23, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 3, 2024ASSIGNED TO EXAMINER